Vicore Pharma’s rights issue registered – conversion of BTA to shares
Not to be released, publication or distribution, directly or indirectly, in or to the United States, Australia, Hong Kong, Singapore, Canada, Japan, New Zealand or South Africa.Mölndal, November 1, 2018 - Vicore Pharma Holding AB (publ) (”Vicore Pharma” or the ”Company”) has completed a rights issue with the subscription period ending on October 3, 2018. The share issue was oversubscribed with 33 percent and provided the Company with SEK 82,4M before issue costs. The rights issue has now been registered with the Swedish Companies Registration Office (sw. Bolagsverket) and last day of